Effects of Matricaria Recutita (L.) in the Treatment of Oral Mucositis

the effects of changing roughness on the flow structure in the bends

flow in natural river bends is a complex and turbulent phenomenon which affects the scour and sedimentations and causes an irregular bed topography on the bed. for the reason, the flow hydralics and the parameters which affect the flow to be studied and understand. in this study the effect of bed and wall roughness using the software fluent discussed in a sharp 90-degree flume bend with 40.3cm ...

Pharmacological Potential of Matricaria recutita-A Review

Matricaria recutita, once it has been called as Marticaria chamomilla, Chamomilla recutita, and Chamomilum nobile family Asteraceae. The main constituents of this plant include the terpenoids α-bisabolol and its oxides and azulenes, including chamazulene. Matricaria recutita shows different pharmacological activities like anti-inflammatory, anticancer, treatment of stress and depression, anti-a...

The Slovak gene pool of German chamomile (Matricaria recutita L.) and comparison in its parameters

Plant habit and production of secondary metabolites in chamomile plants depend on endogenous and exogenous factors that can be divided into two groups (FRANZ 1982): a) morpho-ontogenetic variability, b) genetic variability or genetic determinateness. The activity of these factors is reflected in biomass production, flower drug production, content and composition of essential oil and some other ...

Evaluation of the anti-inflammatory activity of gel with Matricaria recutita L

P02.118. Oral chamomile (Matricaria recutita) extract therapy of Generalized Anxiety Disorder (GAD): trial in progress

Purpose Chamomile is a traditional herb known for its calming effects. We are conducting a long-term, randomized, placebo-substitution study of chamomile for the prevention of recurrent Generalized Anxiety Disorder (GAD) in individuals who have responded to initial, open-label chamomile therapy. We present preliminary results from the trial’s open label phase to offer initial evidence of safety...